Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06999057

Quadriceps Motor Unit Adaptation to Simulated Knee Injury

This study investigates how simulated knee injury-via artificial joint effusion or deafferentation-affects quadriceps motor unit behavior in healthy young adults. Participants will complete neuromuscular testing during a single 2-hour lab session. This research seeks to improve understanding of muscle inhibition and inform interventions after real-world knee trauma.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

University of Central Florida

Orlando, Florida, 32816, United States

Location status: Recruiting

Location contact

Grant E. Norte

CONTACT

[email protected]

407-823-3188

About this study

Using a controlled laboratory model, the investigators will simulate knee injury through two methods: (1) intra-articular saline injection to induce effusion, and (2) intra-articular lidocaine injection to induce sensory deafferentation. Healthy participants aged 18-30 will undergo surface and decomposition EMG, isometric strength testing, and reflex measurements before and after the intervention. The primary outcome is motor unit recruitment characteristics, with secondary outcomes including quadriceps inhibition (Hoffmann reflex) and isometric peak torque. The findings will inform future neuromodulatory approaches in rehabilitation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-30 years
  • Physically active (Tegner ≥ 5)
  • No prior lower-limb surgery or major injury

Exclusion criteria

  • Lower limb surgery or significant injury in past 2 years
  • Cardiopulmonary, neurological, or psychiatric disorders
  • Needle/electrical stimulation anxiety
  • Medications affecting neuromuscular or psychological function
  • Pregnancy
  • Allergic to lidocaine
  • Inability to elicit Hoffmann reflex

Treatment and study plan

Joint Effusion via 60 mL Sterile Saline

Device

Injection of sterile saline into the knee joint to simulate joint swelling and induce quadriceps inhibition.

Intra-articular Lidocaine

Drug

Injection of 7 mL lidocaine into the knee joint to simulate deafferentation by temporarily blocking sensory input.

Sham Injection

Other

Simulated knee injection using a stage needle without skin penetration, used to blind participants and serve as control.

Primary outcomes

  1. Motor Unit Recruitment (amplitude relative to recruitment threshold)

    Time frame: Baseline, 0, 30, and 60 minutes post-intervention

    Measured via surface EMG decomposition

  2. Motor Unit Recruitment (firing rate relative to recruitment threshold)

    Time frame: Baseline, 0, 30, and 60 minutes post-intervention

    Measured via surface EMG decomposition

Secondary outcomes

  1. Quadriceps Inhibition (Hoffmann Reflex)

    Time frame: Baseline, 0 and 60 minutes post-intervention

    Measured with femoral nerve stimulation

  2. Isometric Peak Torque (Quadriceps Strength)

    Time frame: Baseline and 60 minutes post-intervention

    Measured with isokinetic dynamometer (Biodex)

Study contacts

Contact information is provided by the study sponsor or research team.

Grant Norte, Ph.D.

CONTACT

[email protected]

407-823-3188

Meredith Chaput, Ph.D.

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Central Florida

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 31, 2025
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.